ADVERTISEMENT

Sun Pharma Q2 Results Review - India Branded Generic Growth Surprises; Upgrade To 'Buy': Systematix

India branded generics business recorded sales of Rs 42.7 billion, up 11% YoY and 2.9% QoQ, adds the brokerage.

<div class="paragraphs"><p>Tablets. (Source: Castorlystock/ pexels)</p></div>
Tablets. (Source: Castorlystock/ pexels)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to Unlock & Enjoy your 
Subscriber-Only
 benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More